PHILADELPHIA, Jan. 9, 2023 — Rx-360® is pleased to announce its 2023 Board of Directors. As a non-profit, the Board of Directors is positioned to continue driving the Rx-360® mission of pharmaceutical supply chain security, […]
Philadelphia, December 1, 2022 — Rx-360, an international pharmaceutical supply chain consortium, is proud to announce that it has hired Ben Mills as Senior Director of Operations, Joint Audit Program/Quality, and Kristen Farr as Senior […]
Kate Silva is the Head of Quality Management Systems and Audits for MilliporeSigma. In this role, she is responsible for overseeing the global life science framework for compliance with quality, regulatory, and industry standards. Kate […]
Bill Campagna is the Senior Director of Quality for Procurement and Operations for Eli Lilly and Company; and he’s passionate about serving on Rx-360’s Board of Directors. “I’m proud to be part of Rx-360’s Board […]
Philadelphia, February 14, 2022 — Rx-360, an international pharmaceutical supply chain consortium, is proud to announce that Michael Cavacini has been hired as its first Head of Marketing & Membership Development. As a member of Rx-360’s […]
Rx-360 is pleased to announce their 2022 Board of Directors.
Rx-360 has announced the launch of its new website at Rx-360.org.
Rx-360 has announced a broad expansion of its focus on global initiatives that will support its members and their continued efforts in supply chain security.
Rx-360 has opened up nominations for our 2022 Board of Directors. The Consortium has one Board seat open. It is a three year term.